{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:58:43Z","timestamp":1793066323741,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Research, Innovation, and Digitalization in Romania","award":["31PFE\/30.12.2021"],"award-info":[{"award-number":["31PFE\/30.12.2021"]}]},{"name":"Ministry of Research, Innovation, and Digitalization in Romania","award":["31PFE\/30.12.2021"],"award-info":[{"award-number":["31PFE\/30.12.2021"]}]},{"name":"Ministry of Research, Innovation, and Digitalization in Romania","award":["31PFE\/30.12.2021"],"award-info":[{"award-number":["31PFE\/30.12.2021"]}]},{"name":"Ministry of Research, Innovation, and Digitalization in Romania","award":["31PFE\/30.12.2021"],"award-info":[{"award-number":["31PFE\/30.12.2021"]}]},{"name":"Ministry of Research, Innovation, and Digitalization in Romania","award":["31PFE\/30.12.2021"],"award-info":[{"award-number":["31PFE\/30.12.2021"]}]},{"name":"Ministry of Research, Innovation, and Digitalization in Romania","award":["31PFE\/30.12.2021"],"award-info":[{"award-number":["31PFE\/30.12.2021"]}]},{"name":"Ministry of Research, Innovation, and Digitalization in Romania","award":["31PFE\/30.12.2021"],"award-info":[{"award-number":["31PFE\/30.12.2021"]}]},{"name":"Ministry of Research, Innovation, and Digitalization in Romania","award":["31PFE\/30.12.2021"],"award-info":[{"award-number":["31PFE\/30.12.2021"]}]},{"name":"Ministry of Research, Innovation, and Digitalization in Romania","award":["31PFE\/30.12.2021"],"award-info":[{"award-number":["31PFE\/30.12.2021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81020-x","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T05:51:21Z","timestamp":1733377881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bacterial products initiation of alpha-synuclein pathology: an in vitro study"],"prefix":"10.1038","volume":"14","author":[{"given":"Octavian Costin","family":"Ioghen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Gaina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Lambrescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Manole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevinci","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora Maria","family":"Niculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana","family":"Mosoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Cristina","family":"Ceafalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan Ovidiu","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"81020_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R., Sherer, T., Okun, M. S. & Bloemd, B. R. The emerging evidence of the Parkinson pandemic. J. Parkinsons. Dis. 8, S3. https:\/\/doi.org\/10.3233\/JPD-181474 (2018).","journal-title":"J. Parkinsons. Dis."},{"key":"81020_CR2","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/S00702-019-02115-8","volume":"127","author":"A Salamon","year":"2020","unstructured":"Salamon, A., Z\u00e1dori, D., Szpisjak, L., Kliv\u00e9nyi, P. & V\u00e9csei, L. Neuroprotection in Parkinson\u2019s disease: Facts and hopes. J. Neural Transm. 127, 821\u2013829. https:\/\/doi.org\/10.1007\/S00702-019-02115-8 (2020).","journal-title":"J. Neural Transm."},{"key":"81020_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/S42466-019-0039-8","author":"AP Marsh","year":"2019","unstructured":"Marsh, A. P. Molecular mechanisms of proteinopathies across neurodegenerative disease: a review. Neurol. Res. Pract. https:\/\/doi.org\/10.1186\/S42466-019-0039-8 (2019).","journal-title":"Neurol. Res. Pract."},{"key":"81020_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/S00018-022-04240-2","author":"GK Tofaris","year":"2022","unstructured":"Tofaris, G. K. Initiation and progression of \u03b1-synuclein pathology in Parkinson\u2019s disease. Cell. Mol. Life Sci. https:\/\/doi.org\/10.1007\/S00018-022-04240-2 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"81020_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/JNC.14704","volume":"150","author":"L Stefanis","year":"2019","unstructured":"Stefanis, L. et al. How is alpha-synuclein cleared from the cell?. J. Neurochem. 150, 577\u2013590. https:\/\/doi.org\/10.1111\/JNC.14704 (2019).","journal-title":"J. Neurochem."},{"key":"81020_CR6","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1007\/S00018-007-7217-5","volume":"64","author":"GK Tofaris","year":"2007","unstructured":"Tofaris, G. K. & Spillantini, M. G. Physiological and pathological properties of alpha-synuclein. Cell. Mol. Life Sci. 64, 2194\u20132201. https:\/\/doi.org\/10.1007\/S00018-007-7217-5 (2007).","journal-title":"Cell. Mol. Life Sci."},{"key":"81020_CR7","doi-asserted-by":"publisher","first-page":"44405","DOI":"10.1074\/JBC.M308041200","volume":"278","author":"GK Tofaris","year":"2003","unstructured":"Tofaris, G. K., Razzaq, A., Ghetti, B., Lilley, K. S. & Spillantini, M. G. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J. Biol. Chem. 278, 44405\u201344411. https:\/\/doi.org\/10.1074\/JBC.M308041200 (2003).","journal-title":"J. Biol. Chem."},{"key":"81020_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/S12035-012-8280-Y","volume":"47","author":"K Wakabayashi","year":"2013","unstructured":"Wakabayashi, K. et al. The Lewy body in Parkinson\u2019s disease and related neurodegenerative disorders. Mol. Neurobiol. 47, 495\u2013508. https:\/\/doi.org\/10.1007\/S12035-012-8280-Y (2013).","journal-title":"Mol. Neurobiol."},{"key":"81020_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/NRNEUROL.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert, M., Spillantini, M. G., Del Tredici, K. & Braak, H. 100 years of Lewy pathology. Nat. Rev. Neurol. 9, 13\u201324. https:\/\/doi.org\/10.1038\/NRNEUROL.2012.242 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"81020_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211. https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9 (2003).","journal-title":"Neurobiol. Aging"},{"key":"81020_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/NM1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B. & Olanow, C. W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat. Med. 14, 504\u2013506. https:\/\/doi.org\/10.1038\/NM1747 (2008).","journal-title":"Nat. Med."},{"key":"81020_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/NM1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li, J. Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat. Med. 14, 501\u2013503. https:\/\/doi.org\/10.1038\/NM1746 (2008).","journal-title":"Nat. Med."},{"key":"81020_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS22158338","author":"A Jan","year":"2021","unstructured":"Jan, A., Gon\u00e7alves, N. P., Vaegter, C. B., Jensen, P. H. & Ferreira, N. The prion-like spreading of alpha-synuclein in Parkinson\u2019s disease: Update on models and hypotheses. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/IJMS22158338 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"81020_CR14","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1073\/PNAS.1321785111\/-\/DCSUPPLEMENTAL\/PNAS.201321785SI.PDF","volume":"111","author":"AN Sacino","year":"2014","unstructured":"Sacino, A. N. et al. Intramuscular injection of \u03b1-synuclein induces CNS \u03b1-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc. Natl. Acad. Sci. USA 111, 10732\u201310737. https:\/\/doi.org\/10.1073\/PNAS.1321785111\/-\/DCSUPPLEMENTAL\/PNAS.201321785SI.PDF (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"81020_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer, K. M. et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol. Neurodegener. 7, 42. https:\/\/doi.org\/10.1186\/1750-1326-7-42 (2012).","journal-title":"Mol. Neurodegener."},{"key":"81020_CR16","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.15252\/EMBJ.201593411","volume":"35","author":"S Abounit","year":"2016","unstructured":"Abounit, S. et al. Tunneling nanotubes spread fibrillar \u03b1-synuclein by intercellular trafficking of lysosomes. EMBO J. 35, 2120\u20132138. https:\/\/doi.org\/10.15252\/EMBJ.201593411 (2016).","journal-title":"EMBO J."},{"key":"81020_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.AAH3374","author":"X Mao","year":"2016","unstructured":"Mao, X. et al. Pathological \u03b1-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science https:\/\/doi.org\/10.1126\/SCIENCE.AAH3374 (2016).","journal-title":"Science"},{"key":"81020_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/S13024-018-0257-5","author":"N Uemura","year":"2018","unstructured":"Uemura, N. et al. Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol. Neurodegener. https:\/\/doi.org\/10.1186\/S13024-018-0257-5 (2018).","journal-title":"Mol. Neurodegener."},{"key":"81020_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/J.NEULET.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak, H., De Vos, R. A. I., Bohl, J. & Del Tredici, K. Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci. Lett. 396, 67\u201372. https:\/\/doi.org\/10.1016\/J.NEULET.2005.11.012 (2006).","journal-title":"Neurosci. Lett."},{"key":"81020_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/MDS.24921","volume":"27","author":"K Del Tredici","year":"2012","unstructured":"Del Tredici, K. & Braak, H. Lewy pathology and neurodegeneration in premotor Parkinson\u2019s disease. Mov. Disord. 27, 597\u2013607. https:\/\/doi.org\/10.1002\/MDS.24921 (2012).","journal-title":"Mov. Disord."},{"key":"81020_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/J.1365-2990.2007.00874.X","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes, C. H., Del Tredici, K. & Braak, H. Parkinson\u2019s disease: A dual-hit hypothesis. Neuropathol. Appl. Neurobiol. 33, 599\u2013614. https:\/\/doi.org\/10.1111\/J.1365-2990.2007.00874.X (2007).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"81020_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/J.1749-6632.2009.04365.X","volume":"1170","author":"CH Hawkes","year":"2009","unstructured":"Hawkes, C. H., Del Tredici, K. & Braak, H. Parkinson\u2019s disease: The dual hit theory revisited. Ann. N. Y. Acad. Sci. 1170, 615\u2013622. https:\/\/doi.org\/10.1111\/J.1749-6632.2009.04365.X (2009).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"81020_CR23","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/MDS.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans, F. et al. Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov. Disord. 30, 350\u2013358. https:\/\/doi.org\/10.1002\/MDS.26069 (2015).","journal-title":"Mov. Disord."},{"key":"81020_CR24","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/MDS.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns, E. M. et al. Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov. Disord. 32, 739\u2013749. https:\/\/doi.org\/10.1002\/MDS.26942 (2017).","journal-title":"Mov. Disord."},{"key":"81020_CR25","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/MDS.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea, M. S. et al. Microbiota composition and metabolism are associated with gut function in Parkinson\u2019s disease. Mov. Disord. 35, 1208\u20131217. https:\/\/doi.org\/10.1002\/MDS.28052 (2020).","journal-title":"Mov. Disord."},{"key":"81020_CR26","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.2147\/IDR.S254403","volume":"13","author":"W Tang","year":"2020","unstructured":"Tang, W., Zhu, H., Feng, Y., Guo, R. & Wan, D. The impact of gut microbiota disorders on the blood-brain barrier. Infect. Drug Resist. 13, 3351. https:\/\/doi.org\/10.2147\/IDR.S254403 (2020).","journal-title":"Infect. Drug Resist."},{"key":"81020_CR27","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/J.JCMGH.2021.02.007","volume":"11","author":"S Ghosh","year":"2021","unstructured":"Ghosh, S., Whitley, C. S., Haribabu, B. & Jala, V. R. Regulation of intestinal barrier function by microbial metabolites. Cell. Mol. Gastroenterol. Hepatol. 11, 1463\u20131482. https:\/\/doi.org\/10.1016\/J.JCMGH.2021.02.007 (2021).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"81020_CR28","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3233\/JPD-240195\/ASSET\/IMAGES\/10.3233_JPD-240195-FIG4.JPG","volume":"14","author":"G Mercado","year":"2024","unstructured":"Mercado, G., Kaeufer, C., Richter, F. & Peelaerts, W. Infections in the etiology of Parkinson\u2019s disease and synucleinopathies: A renewed perspective, mechanistic insights, and therapeutic implications. J. Parkinsons. Dis. 14, 1301\u20131329. https:\/\/doi.org\/10.3233\/JPD-240195\/ASSET\/IMAGES\/10.3233_JPD-240195-FIG4.JPG (2024).","journal-title":"J. Parkinsons. Dis."},{"key":"81020_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/FCIMB.2021.768108","author":"X Peng","year":"2021","unstructured":"Peng, X., Luo, Z., He, S., Zhang, L. & Li, Y. Blood-brain barrier disruption by Lipopolysaccharide and Sepsis-associated encephalopathy. Front. Cell. Infect. Microbiol. https:\/\/doi.org\/10.3389\/FCIMB.2021.768108 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"81020_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/S13206-012-6209-1\/METRICS","volume":"6","author":"ND Das","year":"2012","unstructured":"Das, N. D. et al. Lipopolysaccharide-mediated protein expression profiling on neuronal differentiated SH-SY5Y cells. Biochip J. 6, 165\u2013173. https:\/\/doi.org\/10.1007\/S13206-012-6209-1\/METRICS (2012).","journal-title":"Biochip J."},{"key":"81020_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2021.710820","volume":"15","author":"ZM Ling","year":"2021","unstructured":"Ling, Z. M. et al. Astrocyte pannexin 1 suppresses LPS-induced inflammatory responses to protect neuronal SH-SY5Y Cells. Front. Cell. Neurosci. 15, 1\u201313. https:\/\/doi.org\/10.3389\/fncel.2021.710820 (2021).","journal-title":"Front. Cell. Neurosci."},{"key":"81020_CR32","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/1873-3468.13038","volume":"592","author":"KK Andersen","year":"2018","unstructured":"Andersen, K. K. et al. Pseudomonas aeruginosa rhamnolipid induces fibrillation of human \u03b1-synuclein and modulates its effect on biofilm formation. FEBS Lett. 592, 1484\u20131496. https:\/\/doi.org\/10.1002\/1873-3468.13038 (2018).","journal-title":"FEBS Lett."},{"key":"81020_CR33","doi-asserted-by":"publisher","DOI":"10.7554\/ELIFE.53111","author":"TR Sampson","year":"2020","unstructured":"Sampson, T. R. et al. A gut bacterial amyloid promotes \u03b1-synuclein aggregation and motor impairment in mice. Elife https:\/\/doi.org\/10.7554\/ELIFE.53111 (2020).","journal-title":"Elife"},{"key":"81020_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/SREP34477","author":"SG Chen","year":"2016","unstructured":"Chen, S. G. et al. Exposure to the functional bacterial amyloid protein curli enhances Alpha-synuclein aggregation in aged fischer 344 rats and Caenorhabditis elegans. Sci. Rep. https:\/\/doi.org\/10.1038\/SREP34477 (2016).","journal-title":"Sci. Rep."},{"key":"81020_CR35","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.2106504118\/-\/DCSUPPLEMENTAL","author":"C Wang","year":"2021","unstructured":"Wang, C., Lau, C. Y., Ma, F. & Zheng, C. Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/PNAS.2106504118\/-\/DCSUPPLEMENTAL (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"81020_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS222111594","author":"C Haikal","year":"2021","unstructured":"Haikal, C. et al. The bacterial amyloids phenol soluble modulins from Staphylococcus aureus catalyze alpha-synuclein aggregation. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/IJMS222111594 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"81020_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/ELIFE.59776","volume":"9","author":"M Zaman","year":"2020","unstructured":"Zaman, M. & Andreasen, M. Cross-talk between individual phenol- soluble modulins in staphylococcus aureus biofilm enables rapid and efficient amyloid formation. Elife 9, 1\u201317. https:\/\/doi.org\/10.7554\/ELIFE.59776 (2020).","journal-title":"Elife"},{"key":"81020_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0006-8993(02)02422-8","volume":"935","author":"C G\u00f3mez-Santos","year":"2002","unstructured":"G\u00f3mez-Santos, C. et al. MPP+ increases alpha-synuclein expression and ERK\/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res. 935, 32\u201339. https:\/\/doi.org\/10.1016\/S0006-8993(02)02422-8 (2002).","journal-title":"Brain Res."},{"key":"81020_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/FNINS.2019.01028","author":"M Ramalingam","year":"2019","unstructured":"Ramalingam, M., Huh, Y. J. & Lee ll, Y. The impairments of \u03b1-synuclein and mechanistic target of rapamycin in rotenone-induced SH-SY5Y cells and mice model of Parkinson\u2019s disease. Front. Neurosci. https:\/\/doi.org\/10.3389\/FNINS.2019.01028 (2019).","journal-title":"Front. Neurosci."},{"key":"81020_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-02126-w","volume":"4","author":"JC Sang","year":"2021","unstructured":"Sang, J. C. et al. Super-resolution imaging reveals \u03b1-synuclein seeded aggregation in SH-SY5Y cells. Commun. Biol. 4, 1\u201311. https:\/\/doi.org\/10.1038\/s42003-021-02126-w (2021).","journal-title":"Commun. Biol."},{"key":"81020_CR41","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1046\/J.1471-4159.2000.0750991.X","volume":"75","author":"M Encinas","year":"2000","unstructured":"Encinas, M. et al. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J. Neurochem. 75, 991\u20131003. https:\/\/doi.org\/10.1046\/J.1471-4159.2000.0750991.X (2000).","journal-title":"J. Neurochem."},{"key":"81020_CR42","doi-asserted-by":"publisher","first-page":"1421270","DOI":"10.3389\/FCIMB.2024.1421270\/BIBTEX","volume":"14","author":"X Li","year":"2024","unstructured":"Li, X. et al. Trends and hotspots on the relationship between gut microbiota and Parkinson\u2019s disease: A bibliometric analysis. Front. Cell. Infect. Microbiol. 14, 1421270. https:\/\/doi.org\/10.3389\/FCIMB.2024.1421270\/BIBTEX (2024).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"81020_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/S41401-023-01150-2","volume":"45","author":"ZX Yang","year":"2024","unstructured":"Yang, Z. X. et al. Addition of \u03b1-synuclein aggregates to the intestinal environment recapitulates Parkinsonian symptoms in model systems. Acta Pharmacol. Sin. 45, 36\u201351. https:\/\/doi.org\/10.1038\/S41401-023-01150-2 (2024).","journal-title":"Acta Pharmacol. Sin."},{"key":"81020_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBAPAP.2019.140263","author":"Z Najarzadeh","year":"2019","unstructured":"Najarzadeh, Z. et al. Bacterial amphiphiles as amyloid inducers: Effect of Rhamnolipid and Lipopolysaccharide on FapC fibrillation. Biochim. Biophys. Acta. Proteins Proteomics https:\/\/doi.org\/10.1016\/J.BBAPAP.2019.140263 (2019).","journal-title":"Biochim. Biophys. Acta. Proteins Proteomics"},{"key":"81020_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/J.YMETH.2024.10.009","author":"AM Gorecki","year":"2024","unstructured":"Gorecki, A. M., Anyaegbu, C. C., Fitzgerald, M., Fuller, K. A. & Anderton, R. S. Imaging flow cytometry reveals LPS-induced changes to intracellular intensity and distribution of \u03b1-synuclein in a TLR4-dependent manner in STC-1 cells. Methods https:\/\/doi.org\/10.1016\/J.YMETH.2024.10.009 (2024).","journal-title":"Methods"},{"key":"81020_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/CBIC.200390020","volume":"4","author":"NC Santos","year":"2003","unstructured":"Santos, N. C., Silva, A. C., Castanho, M. A. R. B., Martins-Silva, J. & Saldanha, C. Evaluation of lipopolysaccharide aggregation by light scattering spectroscopy. Chembiochem 4, 96\u2013100. https:\/\/doi.org\/10.1002\/CBIC.200390020 (2003).","journal-title":"Chembiochem"},{"key":"81020_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS14122799","author":"MS Twigg","year":"2022","unstructured":"Twigg, M. S., Adu, S. A., Sugiyama, S., Marchant, R. & Banat, I. M. Mono-Rhamnolipid Biosurfactants synthesized by pseudomonas aeruginosa detrimentally affect colorectal cancer cells. Pharmaceutics https:\/\/doi.org\/10.3390\/PHARMACEUTICS14122799 (2022).","journal-title":"Pharmaceutics"},{"key":"81020_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/S12931-021-01729-5","author":"WC Kwok","year":"2021","unstructured":"Kwok, W. C., Ho, J. C. M., Tam, T. C. C., Ip, M. S. M. & Lam, D. C. L. Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications. Respir. Res. https:\/\/doi.org\/10.1186\/S12931-021-01729-5 (2021).","journal-title":"Respir. Res."},{"key":"81020_CR49","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/LAM.12440","volume":"61","author":"A Varvaresou","year":"2015","unstructured":"Varvaresou, A. & Iakovou, K. Biosurfactants in cosmetics and biopharmaceuticals. Lett. Appl. Microbiol. 61, 214\u2013223. https:\/\/doi.org\/10.1111\/LAM.12440 (2015).","journal-title":"Lett. Appl. Microbiol."},{"key":"81020_CR50","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3390\/IJMS12021232","volume":"12","author":"TT Nguyen","year":"2011","unstructured":"Nguyen, T. T. & Sabatini, D. A. Characterization and emulsification properties of rhamnolipid and sophorolipid biosurfactants and their applications. Int. J. Mol. Sci. 12, 1232\u20131244. https:\/\/doi.org\/10.3390\/IJMS12021232 (2011).","journal-title":"Int. J. Mol. Sci."},{"key":"81020_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2020.585146","author":"A Zamyatina","year":"2020","unstructured":"Zamyatina, A. & Heine, H. Lipopolysaccharide recognition in the crossroads of TLR4 and Caspase-4\/11 mediated inflammatory pathways. Front. Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2020.585146 (2020).","journal-title":"Front. Immunol."},{"key":"81020_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0051241","author":"R Nakao","year":"2012","unstructured":"Nakao, R., Ramstedt, M., Wai, S. N. & Uhlin, B. E. Enhanced biofilm formation by Escherichia coli LPS mutants defective in Hep biosynthesis. PLoS One https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0051241 (2012).","journal-title":"PLoS One"},{"key":"81020_CR53","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/19490976.2019.1629235","volume":"11","author":"M Stephens","year":"2020","unstructured":"Stephens, M. & von der Weid, P. Y. Lipopolysaccharides modulate intestinal epithelial permeability and inflammation in a species-specific manner. Gut Microbes 11, 421\u2013432. https:\/\/doi.org\/10.1080\/19490976.2019.1629235 (2020).","journal-title":"Gut Microbes"},{"key":"81020_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS11244038","author":"M Kalyan","year":"2022","unstructured":"Kalyan, M. et al. Role of endogenous lipopolysaccharides in neurological disorders. Cells https:\/\/doi.org\/10.3390\/CELLS11244038 (2022).","journal-title":"Cells"},{"key":"81020_CR55","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1021\/ACSCHEMNEURO.8B00733","volume":"10","author":"D Bhattacharyya","year":"2019","unstructured":"Bhattacharyya, D. et al. Lipopolysaccharide from gut microbiota modulates \u03b1-synuclein aggregation and alters its biological function. ACS Chem. Neurosci. 10, 2229\u20132236. https:\/\/doi.org\/10.1021\/ACSCHEMNEURO.8B00733 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"81020_CR56","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/327089","author":"G Bing","year":"2011","unstructured":"Bing, G. & Liu, M. Lipopolysaccharide animal models for Parkinson\u2019s disease. Parkinsons. Dis https:\/\/doi.org\/10.4061\/2011\/327089 (2011).","journal-title":"Parkinsons. Dis"},{"key":"81020_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/BRAINCOMMS\/FCAD285","author":"MJ Hurley","year":"2023","unstructured":"Hurley, M. J. et al. V \u03b1-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: An in vitro proof of concept study. Brain Commun. https:\/\/doi.org\/10.1093\/BRAINCOMMS\/FCAD285 (2023).","journal-title":"Brain Commun."},{"key":"81020_CR58","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/S10482-023-01843-Y","volume":"116","author":"T Misra","year":"2023","unstructured":"Misra, T., Tare, M. & Jha, P. N. Characterization of functional amyloid curli in biofilm formation of an environmental isolate Enterobacter cloacae SBP-8. Antonie Van Leeuwenhoek 116, 829\u2013843. https:\/\/doi.org\/10.1007\/S10482-023-01843-Y (2023).","journal-title":"Antonie Van Leeuwenhoek"},{"key":"81020_CR59","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1016\/J.JMB.2018.07.010","volume":"430","author":"N Van Gerven","year":"2018","unstructured":"Van Gerven, N., Van der Verren, S. E., Reiter, D. M. & Remaut, H. The role of functional amyloids in bacterial virulence. J. Mol. Biol. 430, 3657\u20133684. https:\/\/doi.org\/10.1016\/J.JMB.2018.07.010 (2018).","journal-title":"J. Mol. Biol."},{"key":"81020_CR60","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/02713680902725970","volume":"34","author":"T Kusbeci","year":"2009","unstructured":"Kusbeci, T., Kusbeci, \u00d6. Y., Aktepe, O. C., Yavas, G. & Ermis, S. S. Conjunctival flora in patients with Parkinson\u2019s disease. Curr. Eye Res. 34, 251\u2013256. https:\/\/doi.org\/10.1080\/02713680902725970 (2009).","journal-title":"Curr. Eye Res."},{"key":"81020_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028032","author":"CB Forsyth","year":"2011","unstructured":"Forsyth, C. B. et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS One https:\/\/doi.org\/10.1371\/journal.pone.0028032 (2011).","journal-title":"PLoS One"},{"key":"81020_CR62","doi-asserted-by":"crossref","unstructured":"Perov, S., Lidor, O., Salinas, N., Golan, N., Tayeb-Fligelman, E., Deshmukh, M., Willbold, D., Landau, M. Structural insights into curli CsgA cross-\u03b2 fibril architecture inspire repurposing of anti-amyloid compounds as anti-biofilm agents; 15, (2019).","DOI":"10.1371\/journal.ppat.1007978"},{"key":"81020_CR63","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/J.CELREP.2023.113071","volume":"42","author":"KJ Schmit","year":"2023","unstructured":"Schmit, K. J. et al. Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson\u2019s disease. Cell Rep. 42, 214. https:\/\/doi.org\/10.1016\/J.CELREP.2023.113071 (2023).","journal-title":"Cell Rep."},{"key":"81020_CR64","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin, M. C. et al. Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet (London, England) 364, 1167\u20131169. https:\/\/doi.org\/10.1016\/S0140-6736(04)17103-1 (2004).","journal-title":"Lancet (London, England)"},{"key":"81020_CR65","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/SCIENCE.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A. B. et al. alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302, 841. https:\/\/doi.org\/10.1126\/SCIENCE.1090278 (2003).","journal-title":"Science"},{"key":"81020_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/S41419-022-05330-6","author":"A Iannielli","year":"2022","unstructured":"Iannielli, A. et al. Modeling native and seeded Synuclein aggregation and related cellular dysfunctions in dopaminergic neurons derived by a new set of isogenic iPSC lines with SNCA multiplications. Cell Death Dis. https:\/\/doi.org\/10.1038\/S41419-022-05330-6 (2022).","journal-title":"Cell Death Dis."},{"key":"81020_CR67","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-0716-1437-2_2","volume":"2311","author":"J Kovalevich","year":"2021","unstructured":"Kovalevich, J., Santerre, M. & Langford, D. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol. Biol. 2311, 9\u201323. https:\/\/doi.org\/10.1007\/978-1-0716-1437-2_2 (2021).","journal-title":"Methods Mol. Biol."},{"key":"81020_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13024-017-0149-0","volume":"12","author":"H Xicoy","year":"2017","unstructured":"Xicoy, H., Wieringa, B. & Martens, G. J. M. The SH-SY5Y cell line in Parkinson\u2019s disease research: A systematic review. Mol. Neurodegener. 12, 1\u201311. https:\/\/doi.org\/10.1186\/S13024-017-0149-0 (2017).","journal-title":"Mol. Neurodegener."},{"key":"81020_CR69","doi-asserted-by":"publisher","first-page":"8775","DOI":"10.1007\/S11033-020-05925-2","volume":"47","author":"KB Magalingam","year":"2020","unstructured":"Magalingam, K. B., Radhakrishnan, A. K., Somanath, S. D., Md, S. & Haleagrahara, N. Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line. Mol. Biol. Rep. 47, 8775\u20138788. https:\/\/doi.org\/10.1007\/S11033-020-05925-2 (2020).","journal-title":"Mol. Biol. Rep."},{"key":"81020_CR70","doi-asserted-by":"publisher","DOI":"10.31083\/J.JIN2201020","author":"OC Ioghen","year":"2023","unstructured":"Ioghen, O. C., Ceafalan, L. C. & Popescu, B. O. SH-SY5Y cell line in vitro models for parkinson disease research-old practice for new trends. J. Integr. Neurosci. https:\/\/doi.org\/10.31083\/J.JIN2201020 (2023).","journal-title":"J. Integr. Neurosci."},{"key":"81020_CR71","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.3892\/ETM.2017.4781","volume":"14","author":"LT \u015eener","year":"2017","unstructured":"\u015eener, L. T., Albeniz, G., Din\u00e7, B. & Albeniz, I. iCELLigence real-time cell analysis system for examining the cytotoxicity of drugs to cancer cell lines. Exp. Ther. Med. 14, 1866\u20131870. https:\/\/doi.org\/10.3892\/ETM.2017.4781 (2017).","journal-title":"Exp. Ther. Med."},{"key":"81020_CR72","doi-asserted-by":"publisher","first-page":"14211","DOI":"10.1038\/srep14211","volume":"5","author":"A Sasaki","year":"2015","unstructured":"Sasaki, A., Arawaka, S., Sato, H. & Kato, T. Sensitive western blotting for detection of endogenous Ser129-phosphorylated \u03b1-synuclein in intracellular and extracellular spaces. Sci. Rep. 5, 14211. https:\/\/doi.org\/10.1038\/srep14211 (2015).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81020-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81020-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81020-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T10:49:40Z","timestamp":1733395780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81020-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81020"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81020-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"15 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30306"}}